Guizhou Yibai Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600594.SS

Guizhou Yibai Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 98.52 M

Guizhou Yibai Pharmaceutical Co., Ltd. Cash and Short-Term Investments is USD 98.52 M for the year ending December 31, 2023, a 14.77% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

Guizhou Yibai Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 85.84 M, a 43.67% change year over year.
Guizhou Yibai Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 59.75 M, a -36.84% change year over year.
Guizhou Yibai Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 94.59 M, a -35.63% change year over year.
Guizhou Yibai Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 146.96 M, a 83.50% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Shanghai Stock Exchange: 600594.SS

Guizhou Yibai Pharmaceutical Co., Ltd.

CEO	Ms. Ya Qi Dou
IPO Date	March 23, 2004
Location	China
Headquarters	No. 220-1, Baiyun Avenue
Employees	5,509
Sector	Health Care
Industries Pharmaceuticals Cosmetics

Description

Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.

Key trends

Past 5 years